Dipeptidyl peptidase-4 is widely expressed across various organs and bodily fluids, including the biliary tract (24), kidneys (25), gastrointestinal tract (26), lungs (27), uterus (28), liver (29-32), and immune cells such as T cells, activated natural killer (NK) cells, and activated cells (33-36)
Their lifecycle is shaped by middling actorsurban professionals, activists, and bureaucratswho navigate complex socio-political landscapes while co-producing and implementing policies, mediating between diverse stakeholders, and drawing on successful precedents
Notable Series A funding efforts for new-to-the-scene biotechs with early phase assets include $410 million for Verdiva Bio in 2025 and $400 million for Kailera Therapeutics in late 2024
Biodegradable hollow polydopamine@manganese dioxide as an oxygen self-supplied nanoplatform for boosting chemo-photodynamic cancer therapy
[Taking a GLP-1] is not a failure